Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncoinvent ASA Director's Dealing 2025

Nov 14, 2025

9341_dirs_2025-11-14_0c4f7df9-b470-4da0-8810-fa6507070004.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{0}------------------------------------------------

1 Details of the Primary Insider/Related Party
a) Name HVentures Capital I AB
2 Reason for the notification
a) Position/status Close associate to primary insider and board member of the board of directors,Ingrid Teigland Akay.
b) Initial notification/Amendment Initial notification
3 Details of the company
a) Name Oncoinvent ASA
b) LEI 213800TYYFXKYF3V2A23
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have beenconducted
a) Description of thefinancial instrument,type of instrument Financial instruments/subscription rights linked to shares in Oncoinvent ASA (ISINNO0013251173).
b) Nature of the transaction ISIN: NO 0013674408.
Acceptance/receipt of subscription rights.
c) Price(s) and volume(s) Price(s) Volume(s)
NOK 0 7,996,326
d) Aggregated information
— Aggregated volume 7,996,326
— Price NOK 0
e) Date of the transaction 2025-11-14
f) Place of transaction Outside a trading venue

21827970/1 1